The efficient discrimination of different colorectal polyp subtypes utilizing the novel panel of molecular markers (CA19-9/MUC17/MUC5AC) from the decision tree model, in conjunction with currently available tests and colonoscopy, may aid clinicians in devising improved colon cancer screening recommendations. This evidence concerns the gene MUC17 and malignant colon neoplasm.